Eaton Vance Management Abb Vie Inc. Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Eaton Vance Management holds 4,212,972 shares of ABBV stock, worth $712 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
4,212,972
Previous 4,081,398
3.22%
Holding current value
$712 Million
Previous $625 Million
9.55%
% of portfolio
0.84%
Previous 0.88%
Shares
22 transactions
Others Institutions Holding ABBV
# of Institutions
3,650Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$28.8 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$24.2 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.2 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.66 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.13 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $299B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...